increased tumor latency_Del(4Cdkn2a-Cdkn2b)2Brn/Del(4Cdkn2a-Cdkn2b)2Brn

http://metadb.riken.jp/0009828I129P2OlaHsdFVBNDel4Cdkn2aCdkn2b2BrnDel4Cdkn2aCdkn2b2BrnDel4Cdkn2aCdkn2b2Brn

increased tumor latency_Del(4Cdkn2a-Cdkn2b)2Brn/Del(4Cdkn2a-Cdkn2b)2Brn

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• deletion, Chr 4, Anton Berns 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:5582623

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Del(4Cdkn2a-Cdkn2b)2Brn/Del(4Cdkn2a-Cdkn2b)2Brn

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Del(4Cdkn2a-Cdkn2b)2Brn

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased tumor latency
  http://purl.obolibrary.org/obo/MP_0009828

文献

http://purl.org/net/cito/citesAsAuthority

• Paul. Krimpenfort, et.al., p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a., Nature, 2007, 448
  http://rdf.ncbi.nlm.nih.gov/pubmed/17713536